Jaguar planning to begin commercial launch in Q3 2024 for Gelclair®, the company's third prescription productOral mucositis, also called "chemo…
80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius SE, with an intravenous and subcutaneous…
TORONTO, ON / ACCESSWIRE / April 15, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update on its…
Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 30% Year-Over-Year EPS Grew 45% Year-Over-Year TAMPA, Fla.,…
Collaboration Includes Robust Education and Training to Support Radiologists and Imaging SpecialistsWHIPPANY, N.J.--(BUSINESS WIRE)--Bayer and Hologic, Inc. (Nasdaq: HOLX) today…
PLANO, TX / ACCESSWIRE / April 9, 2024 / In a partnership that signals a game-changing moment for athletic nutrition,…
Toronto, Ontario--(Newsfile Corp. - April 8, 2024) - Celly Nutrition Corp. ("Celly Nu" or the "Company"), announced today that it…
Profitable Acquisition Expected to Contribute More than $8 Million of Annualized Revenue and Over $1 Million of Adjusted EBITDAMIAMI, April…
Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or…